College of Veterinary Medicine
a stack of publications

Publications

  1. Mohammed SI, Steenson L, Kirleis A*. Isolation and characterization of microorganisms associated with the traditional sorghum fermentation for production of Sudanese kisra. Appl Environ Microbiol. 1991 Sep; 57:2529-2533. PMID: 16348551, IF= 3.668. - Dr. Mohammed performed the experiments, analyzed the data and wrote the manuscript.
  2. Mohammed SI, Johnson D, Aronson A*. Loss of binding of the CryIAc toxin to larval midguts but not to the isolated toxin-binding protein from Plodia interpunctella colonies selected for resistance to different Bacillus thuringienesis isolates. Appl Environ Microbiol. 1996 Nov; 62:4168-4173. PMID: 8900008, IF=3.668 – Dr. Mohammed conducted the experiments, analyzed the data and wrote the manuscript.
  3. Mohammed SI, Knapp D, Bastwick D, Foster R, Khan R, Masferrer J, Woerner B, Snyder P, Koki A*. Expression of cyclooxygenase-2 in human transitional cell carcinoma of the urinary bladder. Cancer Res. 1999 Nov; 59:5647 - 5650. PMID: 10582676, IF= 9.329. - Dr. Mohammed performed the experiments, analyzed the data and wrote the manuscript.
  4. Mohammed SI, Coffman K, Glickman NW, Hayek MG, Waters DJ, Schlittler D, DeNicola DB, Knapp DW*.  Prostaglandin E2 concentrations in naturally occurring canine cancer. Prostaglandins Leukot Essent Fatty Acids. 2001 Jan; 64:1-4. PMID: 11161579, IF=1.984 - Dr. Mohammed performed the experiments, analyzed the data and wrote the manuscript.
  5. Knapp DW*, Glickman NW, Mohammed SI, DeNicola DB, Widmer WR, Bonney PL, DeGortari AE. Antitumor effects of piroxicam in spontaneous canine invasive urinary bladder cancer, a relevant model of human invasive bladder cancer. Adv Exp Med Biol. 2002 May; 507:377-380. PMID: 12664613, IF=1.825 - Dr. Mohammed performed the experiments, analyzed the data and wrote the manuscript.
  6. Mohammed SI, Bennett PF, Craig BA, Glickman NW, Mutsaers AJ, Snyder PW, Widmer WR, DeGortari AE, Bonney PL, Knapp DW*. Effects of the cyclooxygenase inhibitor, piroxicam, on tumor response, apoptosis, and angiogenesis in a canine model of human invasive urinary bladder cancer. Cancer Res. 2002 Jan; 62:356-358. PMID: 11809678 IF=9.329. - Dr. Mohammed performed the experiments, analyzed the data and wrote the manuscript.
  7. Mohammed SI, Craig BA, Mutsaers AJ, Glickman NW, Snyder PW, deGortari AE, Schlittler DL, Coffman KT Bonney PL, Knapp DW*.  Effects of the cyclooxygenase inhibitor, piroxicam in combination with chemotherapy on tumor response, apoptosis, and angiogenesis in a canine model of human invasive urinary bladder cancer. Mol Cancer Ther. 2003 Feb; 2:183-188. PMID: 12589035, IF=5.579 - Dr. Mohammed performed the experiments, analyzed the data and wrote the manuscript.
  8. Mohammed SI, Khan KN, Sellers RS, Hayek MG, DeNicola DB, Wu L, Bonney PL, Knapp DW*. Expression of cyclooxygenase-1 and 2 in naturally occurring canine cancer. Prostaglandins Leukot Essent Fatty Acids. 2004 May; 70:479-483. PMID: 15062852, IF= 1.984 - Dr. Mohammed performed the experiments, analyzed the data and wrote the manuscript.
  9. Noblitt LW, Bangari DS, Shukla S, Knapp DW, Mohammed SI, Kinch MS, Mittal SK*. Decreased tumorigenic potential of EphA2-overexpressing breast cancer cells following treatment with adenoviral vectors that express EphrinA1. Cancer Gene Ther. 2004 Nov; 11:757-766. PMID: 15359289, IF= 2.532 – Dr. Mohammed performed the animal studies, tabulated and analyzed the results and wrote the animal section.
  10. Noblitt LW, Bangari DS, Shukla S, Mohammed SI, Mittal SK*. Immunocompetent mouse model of breast cancer for preclinical testing of EphA2-targeted therapy. Cancer Gene Ther. 2005 Jan; 12:46-53. PMID: 15486559, IF=2.532 - Dr. Mohammed performed the animal studies, tabulated and analyzed the results and wrote the animal section.
  11. Mutsaers AJ, Mohammed SI, DeNicola DB, Snyder PW, Glickman NW, Bennett PF, de Gortari AE, Bonney PL, Knapp DW*. Pretreatment tumor prostaglandin E 2 concentration and cyclooxygenase-2 expression are not associated with the response of canine naturally occurring invasive urinary bladder cancer to cyclooxygenase inhibitor therapy. Prostaglandins Leukot Essent Fatty Acids. 2005 Mar; 72:181-186. PMID: 15664302, IF=1.984 – Dr. Mohammed performed the experiments, and co-authored writing the paper. 
  12. Guo S, Tschammer N, Mohammed SI, Guo P*. Specific delivery of therapeutic RNAs to cancer cells via the dimerization mechanism of phi29 motor pRNA. Hum Gene Ther. 2005 Sep; 16:1097-109. PMID: 16149908, IF= 4.062 - Dr. Mohammed performed the animal studies, tabulated and analyzed the results and wrote the animal section.
  13. Liu S*, Hsieh WY, Kim YS, Mohammed SI. Effect of coligands on biodistribution characteristics of ternary ligand 99mTc complexes of a HYNIC-conjugated cyclic RGDfK dimer. Bioconjug Chem. 2005 Nov; 16:1580-1588. PMID: 16287258, IF= 4.513 - Dr. Dr. Mohammed performed the animal studies, tabulated and analyzed the results and wrote the animal section..
  14. Abraham S, Knapp DW, Cheng L, Snyder PW, Mittal SK, Bangari DS, Kinch M, Wu L, Dhariwal J, Mohammed SI*. Expression of EphA2 and Ephrin A-1 in Carcinoma of the Urinary Bladder. Clin Cancer Res. 2006 Jan; 15; 12:353-60. PMID: 16428472, IF=9.619 – Dr. Mohammed mentored Dr. Abraham in performing the experiment, analyzing the data, performed the animal studies and the writing of the manuscript.
  15. Mohammed SI, Dawn D, Abraham S, Snyder P, Waters DJ, Lu M, Wu L, Zheng R, Stewart J, Knapp D*. Cyclooxygenase inhibitors on urinary bladder cancer: in vitro and in vivo Effect. Mol Cancer Ther. 2006 Feb; 5:329-336. PMID: 16505106, IF=5.171 – Dr. Mohammed conceived the idea, performed the experiments, analyzed the data and wrote the manuscript.
  16. Stoyanov AV, Fan ZH, Das C, Ahmadzadeh H, Mei Q, Mohammed SI*.  On the possibility of applying noncovalent dyes for protein labeling in isoelectric focusing. Anal Biochem. 2006 Mar; 15; 350:263-267. PMID: 16460657, IF=5.45 - Dr. Mohammed conceived the idea, interpreted the data and supervised the manuscript preparation.
  17. Wang X, Hockerman GH, Green Iii HW, Babbs CF, Mohammad SI, Gerrard D, Latour MA, London B, Hannon KM, Pond AL*. Merg1a K+ channel induces skeletal muscle atrophy by activating the ubiquitin proteasome pathway. FASEB J. 2006 Jul; 20:1531-1533. PMID: 16723379, IF= 5.043. – Dr. Mohammed performed the animal studies and edited the manuscript.
  18. DiBernardi L, Doré M, Davis JA, Owens JG, Mohammed SI, Guptill CF, Knapp DW*. Study of feline oral squamous cell carcinoma: potential target for cyclooxygenase inhibitor treatment. Prostaglandins, leukotrienes, and essential fatty acids. 2007 Apr; 76(4):245-50. PMID: 17383864, IF=1.984. – Dr. Mohammed performed the experiment and edited the manuscript.
  19. Akin D, Sturgis J, Ragheb K, Sherman D, Burkholder K, Robinson JP, Bhunia AK, Mohammed S, Bashir R*. Bacteria-mediated delivery of nanoparticles and cargo into cells. Nature nanotechnol. 2007 Jul; 2(7):441-9. PMID: 18654330, IF= 38.986.  - Dr. Mohammed designed and performed the animal experiments, wrote the animal studies section and edited the entire manuscript.
  20. Antuofermo E, Miller MA, Pirino S, Xie J, Badve S, Mohammed SI*. Spontaneous mammary intraepithelial lesions in dogs--a model of breast cancer. Cancer Epidemiologic Biomarkers Prev. 2007 Nov; 16(11):2247-56. PMID: 17982119, IF= 4.251- Dr. Mohammed conceived the idea, supervised the experiment, interoperated the data and wrote the manuscript.
  21. Li J, Abraham S, Cheng L, Witzmann FA, Koch M, Xie J, Rahman M, Mohammed SI*. Proteomic-based approach for biomarkers discovery in early detection of invasive urothelial carcinoma. Proteomics Clin Appl. 2008 Jan; 2(1):78-89. PMID: 21136781, IF= 3.814. - Dr. Mohammed conceived the idea, supervised the work, interoperated the data and wrote the manuscript.
  22. Perera CN, Spalding HS, Mohammed SI, Camarillo IG*. Identification of proteins secreted from leptin stimulated MCF-7 breast cancer cells: a dual proteomic approach. Exp Biol Med. 2008 Jun; 233(6):708-20. PMID: 18408141, IF= 2.225. – Dr. Mohammed mentored Miss Perera in her lab and supervised the experiment, interpreted the data and edited the manuscript.
  23. Mohammed SI*, Rahman M. Proteomics and genomics of urinary bladder cancer. Proteomics Clin Appl. 2008 Sep; 2(9):1194-207. PMID: 21136917, IF= 3.814. - Dr. Mohammed conceived the idea and wrote the manuscript with her student.
  24. Madden K, Flowers L, Salani R, Horowitz I, Logan S, Kowalski K, Xie J, Mohammed SI*. Proteomics-based approach to elucidate the mechanism of antitumor effect of curcumin in cervical cancer. Prostaglandins Leukot Essent Fatty Acids. 2009 Jan; 80(1):9-18. PMID: 19058955. IF= 2.653. – Dr. Mohammed conceived the idea, supervised the experiments, interoperated the data and wrote the manuscript.
  25. Mouser P, Miller MA, Antuofermo E, Badve SS, Mohammed SI*. Prevalence and classification of spontaneous mammary intraepithelial lesions in dogs without clinical mammary disease. Vet Pathol. 2010 Mar; 47(2):275-84 . PMID: 20106771. IF= 1.996. - Dr. Mohammed conceived the idea, supervised the work, interoperated the data and co-wrote the manuscript.
  26. Burrai GP, Mohammed SI, Miller MA, Marras V, Pirino S, Addis MF, Uzzau S, Antuofermo E*. Spontaneous feline mammary intraepithelial lesions as a model for human estrogen receptor- and progesterone receptor-negative breast lesions. BMC Cancer. 2010 Apr; 10:156. PMID: 20412586. IF= 3.319. - Dr. Mohammed funded the study and provided the resources, mentored Dr. Burrai, interoperated the data and wrote the manuscript.
  27. Dhawan D, Craig BA, Cheng L, Snyder PW, Mohammed SI, Stewart JC, Zheng R, Loman RA, Foster RS, Knapp DW*. Effects of short-term celecoxib treatment in patients with invasive transitional cell carcinoma of the urinary bladder. Mol Cancer Ther. 2010 May; 9(5):1371-7. PMID: 20423998. IF= 5.579. - Dr. Mohammed performed some of the experimental, performed the animal studies and edited the manuscript.
  28. Xu Z, Liu J, Hong DH, Nguyen VQ, Kim M, Mohammed SI, Kim Y*. Back-directional gated spectroscopic imaging for diffuse light suppression in high anisotropic media and its preclinical applications for microvascular imaging. Selected Topics in Quantum Electronics, IEEE Journal. 2010 July; 16(4):815-823. IF= 3.466. - Dr. Mohammed performed the animal studies analyzed the data and interpreted the results, wrote the animal section, and edited the manuscript.
  29. Lyn-Cook BD, Mohammed SI, Davis C, Word B, Haefele A, Wang H, Hammons G. Gender differences in gemcitabine (Gemzar) efficacy in cancer cells: effect of indole-3-carbinol. Anticancer Res. 2010 Dec; 30(12):4907-13. PMID: 21187469. IF= 1.826. – Dr. Mohammed performed all the experiments in the manuscripts, tabulated and interpreted the results and edited the manuscript.
  30. Kim MR, Morrison H, Mohammed SI*. Effect of a photoactivated rhodium complex in melanoma. Anticancer Drugs. 2011 Oct; 22(9):896-904. PMID: 21642837. IF=2.268. - Dr. Mohammed supervised the work, interpreted the results and wrote the manuscript.
  31. Mohammed SI, Meloni GB, Pinna Parpaglia ML, Marras V, Burrai GP, Meloni F, Pirino S, Antuofermo E*. Mammography and ultrasound imaging of preinvasive and invasive canine spontaneous mammary cancer and their similarities to human breast cancer. Cancer Prev Res (Phila). 2011 Nov; 4(11):1790-8. PMID: 21803985. IF= 3.985. - Dr. Mohammed conceived the idea, supervised the work, analyzed the data, interpreted the data and wrote the manuscript.
  32. Bajaj G, Kim MR, Mohammed SI, Yeo Y*. Hyaluronic acid-based hydrogel for regional delivery of paclitaxel to intraperitoneal tumors. J Control Release. 2012 Mar; 58(3):386-92. PMID: 22178261. IF= 7.441. - Dr. Mohammed designed and supervised the animal studies and data collection, analyzed the data, interpreted the data, and edited the manuscript.
  33. Rahman M, Mohammed SI*. Breast cancer metastasis and the lymphatic system. Oncol Lett. 2015 Sep; 10(3):1233-1239. PMID: 26622656. IF=1.482. Dr. Mohammed conceived the idea and wrote the manuscript with the help of her student.
  34. Burrai GP, Tanca A, De Miglio MR, Abbondio M, Pisanu S, Polinas M, Pirino S, Mohammed SI, Uzzau S, Addis MF, Antuofermo E*. Investigation of HER2 expression in canine mammary tumors by antibody-based, transcriptomic and mass spectrometry analysis: is the dog a suitable animal model for human breast cancer? Tumor Biol. 2015 Nov; 36(11):9083-91. PMID: 26088453. IF= 2.926. Dr. Mohammed conducted some of the experiments in her laboratory and wrote part of the manuscript and edited the entire manuscript.
  35. Samadi AK, Bilsland A, Georgakilas AG, Amedei A, Amin A, Bishayee A, Azmi AS, Lokeshwar BL, Grue B, Panis C, Boosani CS, Poudyal D, Stafforini DM, Bhakta D, Niccolai E, Guha G, Vasantha Rupasinghe HP, Fujii H, Honoki K, Mehta K, Aquilano K, Lowe L, Hofseth LJ, Ricciardiello L, Ciriolo MR, Singh N, Whelan RL, Chaturvedi R, Ashraf SS, Shantha Kumara HM, Nowsheen S, Mohammed SI, Keith WN, Helferich WG, Yang X*. A multi-targeted approach to suppress tumor-promoting inflammation. Semin Cancer Biol. 2015 Dec; 35 Suppl: S151-84. PMID: 25951989. IF= 9.955.
  36. Feitelson MA, Arzumanyan A, Kulathinal RJ, Blain SW, Holcombe RF, Mahajna J, Marino M, Martinez-Chantar ML, Nawroth R, Sanchez-Garcia I, Sharma D, Saxena NK, Singh N, Vlachostergios PJ, Guo S, Honoki K, Fujii H, Georgakilas AG, Bilsland A, Amedei A, Niccolai E, Amin A, Ashraf SS, Boosani CS, Guha G, Ciriolo MR, Aquilano K, Chen S, Mohammed SI, Azmi AS, Bhakta D, Halicka D, Keith WN, Nowsheen S. Sustained proliferation in cancer: Mechanisms and novel therapeutic targets. Semin Cancer Biol. 2015 Dec; 35 Suppl: S25-54. PMID: 25892662. IF= 9.955.
  37. Ferguson LR, Chen H, Collins AR, Connell M, Damia G, Dasgupta S, Malhotra M, Meeker AK, Amedei A, Amin A, Ashraf SS, Aquilano K, Azmi AS, Bhakta D, Bilsland A, Boosani CS, Chen S, Ciriolo MR, Fujii H, Guha G, Halicka D, Helferich WG, Keith WN, Mohammed SI, Niccolai E, Yang X, Honoki K, Parslow VR, Prakash S, Rezazadeh S, Shackelford RE, Sidransky D, Tran PT, Yang ES, Maxwell CA. Genomic instability in human cancer: Molecular insights and opportunities for therapeutic attack and prevention through diet and nutrition. Semin Cancer Biol. 2015 Dec; 35 Suppl: S5-24. PMID: 25869442. IF= 9.955.
  38. Yaswen P, MacKenzie KL, Keith WN, Hentosh P, Rodier F, Zhu J, Firestone GL, Matheu A, Carnero A, Bilsland A, Sundin T, Honoki K, Fujii H, Georgakilas AG, Amedei A, Amin A, Helferich B, Boosani CS, Guha G, Ciriolo MR, Chen S, Mohammed SI, Azmi AS, Bhakta D, Halicka D, Niccolai E, Aquilano K, Ashraf SS, Nowsheen S, Yang X*. Therapeutic targeting of replicative immortality. Semin Cancer Biol. 2015 Dec; 35 Suppl: S104-28. PMID: 25869441. IF= 9.955.
  39. Casey SC, Amedei A, Aquilano K, Azmi AS, Benencia F, Bhakta D, Bilsland AE, Boosani CS, Chen S, Ciriolo MR, Crawford S, Fujii H, Georgakilas AG, Guha G, Halicka D, Helferich WG, Heneberg P, Honoki K, Keith WN, Kerkar SP, Mohammed SI, Niccolai E, Nowsheen S, Vasantha Rupasinghe HP, Samadi A, Singh N, Talib WH, Venkateswaran V, Whelan RL, Yang X, Felsher D*. Cancer prevention and therapy through the modulation of the tumor microenvironment. Semin Cancer Biol. 2015 Dec; 35 Suppl: S199-223. PMID: 25865775. IF= 9.955.
  40. Vinay DS, Ryan EP, Pawelec G, Talib WH, Stagg J, Elkord E, Lichtor T, Decker WK, Whelan RL, Kumara HM, Signori E, Honoki K, Georgakilas AG, Amin A, Helferich WG, Boosani CS, Guha G, Ciriolo MR, Chen S, Mohammed SI, Azmi AS, Keith WN, Bilsland A, Bhakta D, Halicka D, Fujii H, Aquilano K, Ashraf SS, Nowsheen S, Yang X, Choi BK, Kwon BS. Immune evasion in cancer: Mechanistic basis and therapeutic strategies. Semin Cancer Biol. 2015 Dec; 35 Suppl: S185-98. PMID: 25818339. IF= 9.955.
  41. Amin AR, Karpowicz PA, Carey TE, Arbiser J, Nahta R, Chen ZG, Dong JT, Kucuk O, Khan GN, Huang GS, Mi S, Lee HY, Reichrath J, Honoki K, Georgakilas AG, Amedei A, Amin A, Helferich B, Boosani CS, Ciriolo MR, Chen S, Mohammed SI, Azmi AS, Keith WN, Bhakta D, Halicka D, Niccolai E, Fujii H, Aquilano K, Ashraf SS, Nowsheen S, Yang X, Bilsland A, Shin DM. Evasion of anti-growth signaling: A key step in tumorigenesis and potential target for treatment and prophylaxis by natural compounds . Semin Cancer Biol. 2015 Dec; 35 Suppl: S55-77. PMID: 25749195. IF= 9.955.
  42. Wang Z, Dabrosin C, Yin X, Fuster MM, Arreola A, Rathmell WK, Generali D, Nagaraju GP, El-Rayes B, Ribatti D, Chen YC, Honoki K, Fujii H, Georgakilas AG, Nowsheen S, Amedei A, Niccolai E, Amin A, Ashraf SS, Helferich B, Yang X, Guha G, Bhakta D, Ciriolo MR, Aquilano K, Chen S, Halicka D, Mohammed SI, Azmi AS, Bilsland A, Keith WN, Jensen LD. Broad targeting of angiogenesis for cancer prevention and therapy. Semin Cancer Biol. 2015 Dec; 35 Suppl: S224-43. PMID: 25600295. IF= 9.955.
  43. Block KI, Gyllenhaal C, Lowe L, Amedei A, Amin AR, Amin A, Aquilano K, Arbiser J, Arreola A, Arzumanyan A, Ashraf SS, Azmi AS, Benencia F, Bhakta D, Bilsland A, Bishayee A, Blain SW, Block PB, Boosani CS, Carey TE, Carnero A, Carotenuto M, Casey SC, Chakrabarti M, Chaturvedi R, Chen GZ, Chen H, Chen S, Chen YC, Choi BK, Ciriolo MR, Coley HM, Collins AR, Connell M, Crawford S, Curran CS, Dabrosin C, Damia G, Dasgupta S, DeBerardinis RJ, Decker WK, Dhawan P, Diehl AM, Dong JT, Dou QP, Drew JE, Elkord E, El-Rayes B, Feitelson MA, Felsher DW, Ferguson LR, Fimognari C, Firestone GL, Frezza C, Fujii H, Fuster MM, Generali D, Georgakilas AG, Gieseler F, Gilbertson M, Green MF, Grue B, Guha G, Halicka D, Helferich WG, Heneberg P, Hentosh P, Hirschey MD, Hofseth LJ, Holcombe RF, Honoki K, Hsu HY, Huang GS, Jensen LD, Jiang WG, Jones LW, Karpowicz PA, Keith WN, Kerkar SP, Khan GN, Khatami M, Ko YH, Kucuk O, Kulathinal RJ, Kumar NB, Kwon BS, Le A, Lea MA, Lee HY, Lichtor T, Lin LT, Locasale JW, Lokeshwar BL, Longo VD, Lyssiotis CA, MacKenzie KL, Malhotra M, Marino M, Martinez-Chantar ML, Matheu A, Maxwell C, McDonnell E, Meeker AK, Mehrmohamadi M, Mehta K, Michelotti GA, Mohammad RM, Mohammed SI, Morre DJ, Muralidhar V, Muqbil I, Murphy MP, Nagaraju GP, Nahta R, Niccolai E, Nowsheen S, Panis C, Pantano F, Parslow VR, Pawelec G, Pedersen PL, Poore B, Poudyal D, Prakash S, Prince M, Raffaghello L, Rathmell JC, Rathmell WK, Ray SK, Reichrath J, Rezazadeh S, Ribatti D, Ricciardiello L, Robey RB, Rodier F, Rupasinghe HP, Russo GL, Ryan EP, Samadi AK, Sanchez-Garcia I, Sanders AJ, Santini D, Sarkar M, Sasada T, Saxena NK, Shackelford RE, Shantha Kumara HM, Sharma D, Shin DM, Sidransky D, Siegelin MD, Signori E, Singh N, Sivanand S, Sliva D, Smythe C, Spagnuolo C, Stafforini DM, Stagg J, Subbarayan PR, Sundin T, Talib WH, Thompson SK, Tran PT, Ungefroren H, Vander Heiden MG, Venkateswaran V, Vinay DS, Vlachostergios PJ, Wang Z, Wellen KE, Whelan RL, Yang ES, Yang H, Yang X, Yaswen P, Yedjou C, Yin X, Zhu J, Zollo M. Designing a broad-spectrum integrative approach for cancer prevention and treatment. Semin Cancer Biol. 2015 Dec; 35 Suppl: S276-304. PMID: 26590477. IF= 9.955. 
  44. Mohammad RM, Muqbil I, Lowe L, Yedjou C, Hsu HY, Lin LT, Siegelin MD, Fimognari C, Kumar NB, Dou QP, Yang H, Samadi AK, Russo GL, Spagnuolo C, Ray SK, Chakrabarti M, Morre JD, Coley HM, Honoki K, Fujii H, Georgakilas AG, Amedei A, Niccolai E, Amin A, Ashraf SS, Helferich WG, Yang X, Boosani CS, Guha G, Bhakta D, Ciriolo MR, Aquilano K, Chen S, Mohammed SI, Keith WN, Bilsland A, Halicka D, Nowsheen S, Azmi AS. Broad targeting of resistance to apoptosis in cancer. Semin Cancer Biol. 2015 Dec; 35 Suppl: S78-103. PMID: 25936818. IF= 9.955.
  45. Tayyari F, Gowda N, Olopade OF, Berg R, Yang H, Lee M, Ngwa W, Mittal S, Raftery D*, Mohammed SI*. Metabolic profiles of triple-negative and luminal a breast cancer subtypes in African-American identify key metabolic differences. Oncotarget 2018; 9:11677-11690. PMID: 29545929. IF=5.168. - Dr. Mohammed conceived the idea, performed part of the experimentin her lab, interpreted results and wrote all manuscript.
  46. Abdelmegeed S and Mohammed SI*. Canine carcinoma in situ as a model for human disease. Oncology Letters. doi.org/10.3892/ol.2018.8411. IF=1.554. - Dr. Mohammed conceived the idea, mentored her student and supervised the writing and edited the manuscript.
  47. Hussain NF, and Mohammed SI*. Significance of using SYPRO ruby against CBB R-250 for visualizing haematoxylin stained proteins in gels. Oncol Res Ther. 2018: JONT-141. DOI: 10.29011/2574-710X. 000041. IF= not determined. - Dr. Mohammed conceived the idea, mentored Dr. Hussain, supervised the expereiments, and wrote the manuscript.
  48. Mohammed SI*, Torres-Luquis O, Lloyd F, Walls E.  En route to the lymph node: lymph circulating tumor cells are phenotypically different from tumor cells circulating in the blood. Cancer Cell Report. Dr. Mohammed conceived the idea, performed the experiment, mentored and supervised the experiments and wrote the manuscript.
  49. Torres-Luquis O, Madden K, Berg R, Olopade OF, Lloyd F, and Mohammed SI*. Proteomic landscape of triple-negative and luminal A breast cancer in African-American. Cancer Journal. Dr. Mohammed conceived the idea, performed the experiment, mentored and supervised Ms. Torres-Luquis in perfuming the experiments and Dr. Mohammed wrote the manuscript.
  50. Mohammed SI*, Uttukar S, Ramos Cardona X, Cui Z, Atallah N, Miller P, and Zhang G. Differential Gene Expression in Canine Model of Breast Triple-Negative Ductal Carcinoma in Situ. Elife. - Dr. Mohammed conceived the idea, supervised the experiments, and wrote the manuscript.
  51. Stefanska B and Sulma Mohammed SI*. Analysis of DNA methylation of DCIS progression in dog model of breast cancer. Cancer Research. -  Dr. Mohammed conceived the idea, supervised the experiments, and wrote the manuscript.
  52. N’Dri N, Fadul H, Hussein N, Lyn-Cook B, Hammons G, Mohammed K and Mohammed SI*. Proteomics of Pancreatic Cancer. Frontier on oncology. - Dr. Mohammed conceived the idea, supervised the experiments, and wrote the manuscript.
  53. Sayedahmed EE, Kumari R, Shukla S, Hassan AO, Mohammed SI, York IA, Gangappa S, Sambhara S and Mittal SK. Longevity of adenovirus vector immunity and its implications for vaccine efficacy. Vaccine. Dr. Mohammed helped in data analysis and edited the manuscript. 
  54. Elgaili EM, Abuidris DO, Rahman M, Michalek AM, Mohammed SI*. Breast cancer burden in central Sudan. Int J Women’s Health. 2010 Aug; 2:77-82. PMID: 21072300. IF= 2.68 - Dr. Mohammed conceived the idea, instructed the work, analyzed the data and wrote the manuscript.
  55. Mohammed SI, Springfield S, Das R*. Role of epigenetics in cancer health disparities. Methods Mol Biol. 2012; 863:395-410. PMID: 22359308. IF= 1.29 - Dr. Mohammed searched the literature and wrote and revised the manuscript.
  56. Mohammed SI*. Sudan First International Conference on Breast Cancer. Sudan Med J. 2012 Jan; 48(1):58-63. IF= not determined - Dr. Mohammed organized the meeting, took the notes during the meeting and wrote the manuscript.
  57. Mohammed SI*, Williams CK, Ndom P, Holland JF. The African Organization for Research and Training in Cancer: historical perspective. Curr Oncol. 2012 Oct; 19(5):272-6. PMID: 23144576. IF= 1.829 - Dr. Mohammed conceived the idea, gathered the data, and wrote the manuscript.
  58. Abuidris DO, Elsheikh A, Ali M, Musa H, Elgaili E, Ahmed AO, Sulieman I, Mohammed SI*. Breast-cancer screening with trained volunteers in a rural area of Sudan: a pilot study. Lancet Oncol. 2013 Apr; 14(4):363-70. PMID: 23375833. IF= 33.900 - Dr. Mohammed conceived the idea, instructed the work, analyzed the data and wrote the manuscript.

    Breast cancer has a low cure rate in low-income and middle-income countries because patients often present with late-stage disease that has metastasized to other organs. The work in this manuscript assessed whether the implementation of a cancer awareness and breast examination program that uses local, volunteer women could increase the early detection of breast cancer in a rural area of sub-Saharan Africa. The results show that a screening program using local volunteers can increase the detection of breast cancer in asymptomatic women in low-income rural communities. The findings can inform policy-makers' decisions in the design of cancer control programs in Sudan and other similar areas in sub-Saharan Africa.
  59. Saeed IE, Abuidris DA, Mohammed KH, Mohammed SI*. Cancer Registry in Sudan: a Brief Overview. Internet J Epidemiol. 2013 Sep; 11(2). IF= 0.30 - Dr. Mohammed conceived the idea, instructed the data collection, analyzed the data and wrote the manuscript.
  60. Abuidris DO*, Alsnousi M, Sid Ahmed R, Elhaj A, Eltayeb E, Mohammed SI. Successful pregnancy after breast cancer treatment in a Sudanese patient. Sudan Med. Monitor 2014 Jan; 9(1):45-47. IF=not determined – Dr. Mohammed wrote the manuscript.
  61. Mohammed ME; Hassan AM; Abdelhad HA; Elsadig MG; Adam DM; Elmamoun K; Hamid R; Elias H; Abdallah M; Abdelkarim Z; Elwal NE; Mohammed SI*. Burden and pattern of cancer in the Sudan, 2000-2006. British J Med Medical Res. 2014 Feb; 5(5):1231-1243. IF=not determined - Dr. Mohammed conceived the idea, instructed the data collection, analyzed the data and wrote the manuscript.
  62. Saeed IE, Weng HY, Mohamed KH, Mohammed SI*. Cancer incidence in Khartoum, Sudan: first results from the Cancer Registry, 2009-2010. Cancer Med. 2014 Aug; 3(4):1075-84. PMID: 24821265. IF= 2.915 - Dr. Mohammed conceived the idea, instructed the data collection, analyzed the data and wrote the manuscript.
  63. Elamin A, Ibrahim ME, Abuidris D, Mohamed KE, Mohammed SI*. Part I: cancer in Sudan—burden, distribution, and trends breast, gynecological, and prostate cancers. Cancer Med. 2015 Mar; 4(3):447-56. PMID: 25641872. IF= 2.915 - Dr. Mohammed conceived the idea, supervised the literature review in her lab at Purdue, and wrote the manuscript.
  64. Ngwa W*, Ngoma T, Zietman A, Mayr N, Elzawawy A, Winningham TA, Balogun O, Enwerem-Bromson N, Ntizimira C, Olopade OI, Oluwole D, Odedina F, Williams M, Flanigan J, Asana L, Ngwa K, Avery S, Pollard JM, Roland T, Funwi-gabga N, Mbarika V, Hardenbergh P, Winkfield K, Pipman Y, Stefan C, Ngoma M, Mohammed SI, Katz M, Erno S, Moni J, Fitzgerald T, Tonlaar N, Efstathiou J, Gierga D, Ayo C, Knaul F, Gospodarowicz M, Makrigiorgos GM, Nguyen PL. Closing the cancer divide through Ubuntu: Information and communication technology-powered models for global radiation oncology. Int J Radiat Oncol Biol Phys. 2016 Mar; 94(3):440-9. PMID: 26867873. IF= 5.133. Dr. Mohammed conceived the idea and discussed the idea with Dr. Ngwa and contributed to the writing of the manuscript.
  65. Mohammed SI*, Ren W, Flowers L, Rajwa B, Chibwesha CJ, Parham GP, Irudayaraj JM. Point-of-care test for cervical cancer in LMICs. Oncotarget 2016 Apr; 7(14):18787-97. PMID: 26934314. IF= 5.009 - Dr. Mohammed conceived the idea, supervised the work in her lab, analyzed the data and wrote the manuscript.

    Cervical cancer screening using Papanicolaou's smear test has been highly effective in reducing death from this disease. However, this test is unaffordable in low- and middle-income countries (LMIC), and its complexity has limited wide-scale uptake. The study described identification of sensitive and specific cervical biomarkers and development of point-of-care cervical cancer diagnostic test for the use in LMIC.
  66. Abuidris DO, Weng H, Elhaj AM, Eltayeb EA, Elsanousi M, Ibnoof RS, Mohammed SI*. Incidence and survival rates of ovarian cancer in low-income women. Mol Clin Oncol. 2016 Dec; 5(6):823-828. PMID: 28105363. IF=1.5 - Dr. Mohammed instructed data collection, analyzed the data with the help of Dr. Weng, and wrote the manuscript.
  67. Ginsburg O*, Badwe R, Boyle P, Derricks G, Dare A, Evans T, Eniu A, Jimenez G, Kutluk T, Lopes G, Mohammed SI, Qiao Y, Rashid S, Summers D, Sarfati D, Temmerman M, Trimble E, Padela A, Aggarwal A, Sullivan R. Changing the global policy paradigm to deliver safe, equitable and affordable care for women’s cancers. Lancet 2017 Feb; 389(10071):871-880. PMID: 27814964. IF=44.002. Dr. Mohammed was invited to a two-day meeting in Canada to discuss and outline the manuscript as well as contributed to writing of the manuscript
    The link below shows The Lancet Series Homepage and the manuscript contributors http://www.globalwomenscancers.com/events.html (See Appendix III)

Referred Journal Articles Submitted Related to Engagement

  1. Abdulrahman M, Elimam MA, Osman AA, Elagib AA, Shaheen SM, N’dri N, Mohammed SI. The differences of cancer susceptibility between males and females in Sudan. Cancer Epidemiol. IF=2.8 – Dr. Mohammed mentored Dr. Abdulrahman in how to collect cancer data, analyzed the data and co-wrote the manuscript.
  2. Ngwa W, Taylor D, Foote M, Mohammed SI, Irabor OC, Asana L, Elzawawy A, Palmer D, Shangarai H, Nyanganyi A, Mulamula L, Ngoma T, Avery S, Herman A, Dabney R, Nwabueze E, Bueker R, Azeh I, Ignatius A, Bongkishiy M, Patcha S, Nkengasong J, Hammad N, Chinegwadoh F,  Williams M, Fitzgerald T, Tefera G, Garvey J, Adeyi O, Ntizimira C, Mukantabana M, Chimhombori A, Haufiku B, Knaul F, Gashumba D. Engaging the African Diaspora in Global Health: An Imperative. N Engl. J Med. IF=72.406. - Dr. Mohammed conceived the idea with Dr. Ngwa and contributed to the writing of the manuscript
  3. Aburidirs D, Weng H, Mohammed SI*. Prostate cancer in Sudan. Cancer Epidemiol. IF=2.08 – Dr. Mohammed analyzed the data with Dr. Weng and wrote the manuscript

Editorials Related to Discovery

  1. Miller MA*, Mohammed SI. In pursuit of a prognostic marker in canine mammary tumors. Vet J. 2011 Sep; 189 (3):245. PMID: 21277242. IF= 1.755. - Dr. Mohammed engaged in the planning discussion and co-authored the paper
  2. Mohammed SI. Cancer in South Sudan, Lancet Global Health, Oct 2013. IF= 17.686. Dr. Mohammed was invited by Lancet Global Health to write this blog
  3. Mohammed SI*. International Journal of Cancer and Clinical Research- Committed to ensure quality publication in cancer research. Int J Cancer and Clin Res. 2014 August; 1(1):1. IF=0.35 – a new journal – As an editor-in-chief, Dr. Mohammed wrote this editorial for the inauguration of the International Journal of Cancer and Clinical Research.
  4. Mohammed SI*, Harford JB. Sorting reality from what we think we know about breast cancer in Africa. PLoS Med. 2014 Sep; 11(9):e1001721. PMID: 25203049. IF=13.585. Dr. Mohammed was invited by Plos Medicine Journal to write this editorial in response to a manuscript reviewed by Dr. Mohammed for the journal.

Book Chapters Related to Discovery

  1. Knapp DW, Mohammed SI, Waters DJ, Hayek MG. Prostaglandin E2 concentrations in naturally occurring canine cancer and in canine cancer cell lines. Recent Advances in Canine and Feline Nutrition. Volume III: 2000 Iams Nutrition Symposium Proceedings, pp. 565-571. Chicago, IL.
  2. Mohammed SI, Springfield S, Das R. (2012). Role of epigenetics in cancer health disparities. In Ramona G Dumitrescu and Mukesh Verma (Eds.). Cancer Epigenetics Methods and Protocols. PP. 395-410. USA: Humana Press, Springer.
  3. Mohammed SI. 2017. Social-biological transition and cancer: prospects for Africa. Muntaser Ibrahim and Charles Rotimi (Eds.). Genetics of African Populations in Health and Disease. United Kingdom: Cambridge Press. In press.